LP-184
LP-184 (compound 6), an acylfulvene analog, inhibits tumor growth. LP-184 has potent anti-cancer activity in the ovarian, colon, prostate and pancreatic cell lines. (patent WO2007019308A2) .
Product Specifications
CAS Number
[924835-67-6]
UNSPSC
12352211
Target
DNA Alkylator/Crosslinker; Drug Derivative
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lp-184.html
Purity
99.37
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C1(CC1)[C@@](O)(C2=O)C)=C3C2=CC(C)=C3CN(O)C(N)=O
Molecular Formula
C16H20N2O4
Molecular Weight
304.34
References & Citations
[1]Trevor C. Mcmorris, et al. Illudin analogs useful as anticancer agents. WO2007019308A2.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1447955-01 0.5 mg (E-Coli)
Recombinant Yersinia pestis Na (+)-translocating NADH-quinone reductase subunit F (nqrF), partial
Ask
View Details MBS1447955-02 0.05 mg (Baculovirus)
Recombinant Yersinia pestis Na (+)-translocating NADH-quinone reductase subunit F (nqrF), partial
Ask
View Details 
MBS1447955-03 0.5 mg (Yeast)
Recombinant Yersinia pestis Na (+)-translocating NADH-quinone reductase subunit F (nqrF), partial
Ask
View Details MBS1447955-04 0.05 mg (Mammalian-Cell)
Recombinant Yersinia pestis Na (+)-translocating NADH-quinone reductase subunit F (nqrF), partial
Ask
View Details